Genentech I/O chief Dan Chen heads to an upstart biotech looking to create a landmark advance on antibodies
One of the top scientific leaders behind the emergence of PD-1/L1 checkpoint inhibitors has left Genentech to take the chief medical officer’s job at a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
